Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study
Jitao Wang, Zhiyun Hou, Jianxin Liu, Ye Gu, Yunhong Wu, Zhenhuai Chen, Jiansong Ji, Shiqi Diao, Yuanwang Qiu, Shengqiang Zou, Aiguo Zhang, Nina Zhang, Fengxian Wang, Xue Li, Yan Wang, Xing Liu, Cheng Lv, Shubo Chen, Dengxiang Liu, Xiaolin Ji, Chao Liu, Tao Ren, Jingwei Sun, Zhongwei Zhao, Fazong Wu, Fenxiang Li, Ruixu Wang, Yan Yan, Shiliang Zhang, Guohong Ge, Jiangbo Shao, Shiying Yang, Chuan Liu, Yifei Huang, Dan Xu, Xiaoguo Li, Jingwen Ai, Qing‐Yu He, Ming‐Hua Zheng, Liting Zhang, Qing Xie, Don C. Rockey, Jonathan Fallowfield, Wenhong Zhang, Xiaolong Qi
Topics & Concepts
ImmunogenicityCoronavirus disease 2019 (COVID-19)VaccinationMedicineFatty liverVirologyDisease2019-20 coronavirus outbreakAlcoholic liver diseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyOutbreakInternal medicineAntibodyInfectious disease (medical specialty)CirrhosisLiver Disease Diagnosis and TreatmentCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research